| 1 |
c-Jun N-terminal kinase activity is required for efficient respiratory syncytial virus production
Caly L, Li HM, Bogoyevitch MA, Jans DA
Biochemical and Biophysical Research Communications, 483(1), 64, 2017 |
| 2 |
Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production
Hu MJ, Li HM, Bogoyevitch MA, Jans DA
Biochemical and Biophysical Research Communications, 489(4), 460, 2017 |
| 3 |
Expression and antigenicity of recombinant human respiratory syncytial virus glycoproteins having different affinity tags
Lee HS, Kim AR, Kim K, Lee WJ, Kim SS, Kim YJ
Protein Expression and Purification, 132, 1, 2017 |
| 4 |
A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation
Choi MS, Heo J, Yi CM, Ban J, Lee NJ, Lee NR, Kim SW, Kim NJ, Inn KS
Biochemical and Biophysical Research Communications, 477(3), 311, 2016 |
| 5 |
Progressive Changes in Inflammatory and Matrix Adherence of Bronchial Epithelial Cells with Persistent Respiratory Syncytial Virus (RSV) Infection (Progressive Changes in RSV Infection)
Liu XA, Qin XQ, Xiang Y, Liu HJ, Gao G, Qin L, Liu C, Qu XP
International Journal of Molecular Sciences, 14(9), 18024, 2013 |
| 6 |
Purification of human respiratory syncytial virus fusion glycoprotein
Zheng YP, Tang YN, Fu YH, He JS, Wang XB, Hong T
Protein Expression and Purification, 81(1), 115, 2012 |
| 7 |
A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus
Fu YH, He JS, Wang XB, Zheng XX, Wu Q, Xie C, Zhang M, Wei W, Tang Q, Song JD, Qu JG, Hong T
Biochemical and Biophysical Research Communications, 395(1), 87, 2010 |
| 8 |
Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice
Fu YH, He JS, Zheng XX, Wu Q, Zhang M, Wang XB, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song JD, Qu JG, Zhang Y, Wang X, Hong T
Biochemical and Biophysical Research Communications, 381(4), 528, 2009 |
| 9 |
The RSV F and G glycoproteins interact to form a complex on the surface of infected cells
Low KW, Tan T, Ng K, Tan BH, Sugrue RJ
Biochemical and Biophysical Research Communications, 366(2), 308, 2008 |
| 10 |
Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-Like protein in mice
Zeng RH, Zhang ZY, Mei XG, Gong W, Wei L
Biochemical and Biophysical Research Communications, 377(2), 495, 2008 |
